Search Results 1531-1540 of 20540 for hepatitis

1. Study to Investigate the Safety, Pharmacokinetic Profiles and the Efficacy of Tinostamustine, a First-in-Class Alkylating Histone Deacetylase Inhibition Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   ... Hepatitis B or Hepatitis C; Chemotherapy, radiotherapy, biologics, and/or other treatment with immunotherapy not completed four (4) weeks prior to first dose ...

2. Escalating Dose Study in Subjects with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia - Mayo Clinic

   Positive for Hepatitis B surface antigen or Hepatitis C-virus. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...

3. A Study to Evaluate the Effectiveness and Safety of Pemigatinib in Previously-treated, Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207) - Mayo Clinic

   Evidence of active hepatitis B virus (HBV) or hepatitis C virus (HCV) infection (defined as elevated transaminases or cirrhosis; chronic HBV/HCV infection ...

4. Primary Biliary Cholangitis (PBC) Clinical Trials - Mayo Clinic Research

   ... hepatitis (AIH), overlap AIH with Primary Biliary Cirrhosis (AIH-PBC), overlap AIH with Primary Sclerosing Cholangitis (AIH-PSC), and drug-induced ...

5. A First-in-Human, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BJ-005 in Patients With Advanced Solid Tumor or Lymphoma - Mayo Clinic

   Active HIV, hepatitis B or hepatitis C virus. Active tuberculosis. Anticancer therapy or radiation therapy within 5 half-lives or 4 weeks (whichever is ...

6. Controlled Trial Evaluating Avacopan in C3 Glomerulopathy - Mayo Clinic

   Positive hepatitis B virus (HBV), hepatitis C virus (HCV), or human immunodeficiency virus (HIV) viral screening test indicative of acute or chronic infection.

7. A Study of the Safety and Drug/Body Interactions of LAM-002A for Patients with Non-Hodgkin's Lymphoma - Mayo Clinic

   ... hepatitis B or hepatitis C; Is lactating and breast feeding; Unable or unwilling to abide by the study protocol or cooperate fully with the Investigator or ...

8. A Study of Niraparib Combined with Pembrolizumab (MK-3475) in Patients who have Triple-Negative Breast Cancer or Ovarian Cancer - Mayo Clinic

   Known active hepatitis B or hepatitis C; Active autoimmune disease that has required systemic treatment in the past 2 years (ie, with use of disease ...

9. Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701) - Mayo Clinic

   Seropositive for any of the following: HIV ab, hepatitis B sAg or polymerase chain reaction (PCR)+, or hepatitis C ab or PCR+. More information. Publications.

10. Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1 - Mayo Clinic

    ... hepatitis B, hepatitis C or HIV infection; For melanoma: Uveal melanoma or LDH >1.1 x ULN; Brain metastases considered unstable as: Without confirmed ...